Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
KRAS mutation
100%
Combined Analysis
100%
Prognostic Marker
100%
KRAS Oncogene
100%
Oncogene mutation
100%
Relative Risk
80%
Existing Data
40%
Prognostic Indicator
40%
Analytical Method
20%
Meta-analysis
20%
Multivariate Analysis
20%
Risk of Death
20%
Confidence Interval
20%
Adjuvant Therapy
20%
K-ras
20%
Patient Selection
20%
Survival Data
20%
Improved Survival
20%
Selection Bias
20%
Non-small Cell Lung Cancer Patients
20%
Unmeasured Confounding
20%
Metastatic Disease
20%
Risk Analysis
20%
Possible Sources
20%
RAS Oncogene
20%
Variance-based
20%
Year of Diagnosis
20%
Prognostic Biomarker
20%
Prognostic Role
20%
Mutation-negative
20%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Ras Signaling
100%
Biological Marker
20%
Disease
20%
Adjuvant Therapy
20%
Meta-Analysis
20%
Metastatic Carcinoma
20%
Multivariate Analysis
20%
Selection Bias
20%
Analytic Method
20%
Treatment of Non-Small Cell Lung Cancer
20%
Biochemistry, Genetics and Molecular Biology
Oncogene K Ras
100%
Analytical Method
50%
Multivariate Analysis
50%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Biological Marker
20%
Metastasis
20%
Disease
20%